NSEInvestor Presentation▲ PositiveResults30 Jul 2026
Apcotex Industries Limited
Investor Presentation
Apcotex Industries Limited has released its Q1-FY27 earnings presentation, showcasing a 40% year-on-year growth in revenue from operations, driven by higher price realisations despite lower sales volumes. The company delivered its strongest quarterly financial performance with the highest-ever EBITDA, PBT, and PAT in its history. However, export volumes were impacted by geopolitical tensions in West Asia, and working capital requirements increased due to elevated raw material prices.
BSECompany Update▲ PositiveOrder Win30 Jul 2026
B.R.Goyal Infrastructure Ltd
Receipt of LOA from Uttar Pradesh Expressways Industrial Development Authority for collection of user fees and O & M of Toll Plazas along Bundelkhand Expressway.
B.R.Goyal Infrastructure Ltd has received a work order from Uttar Pradesh Expressways Industrial Development Authority for the Collection of User Fees and O&M of Toll Plazas along Bundelkhand Expressway. The total accepted value of the said work order is Rs. 377,54,37,907.50 for a period of two years.
NSEInvestor Presentation▲ PositiveResults30 Jul 2026
eMudhra Limited
Investor Presentation
eMudhra Limited has informed the Exchange about Investor Presentation, providing a summary of the company's financial results for the quarter ended June 30, 2026, and highlighting its growth in revenue and profitability, with an increasing focus on product-led growth.
NSEPress Release▲ PositiveM&A30 Jul 2026
Piccadily Agro Industries Limited
Press Release
Piccadily Agro Industries Limited has announced that its brand Indri has won top honours at the International Whisky Competition 2026, securing the top three positions in both the Best Indian Whisky and Best Single Malt Indian Whisky categories. This achievement is seen as a historic moment for India's luxury whisky industry, with Indri becoming the only Indian whisky brand to score above 90 points at this year's competition.
BSEResult▲ PositiveResults30 Jul 2026
Hester Biosciences Ltd
Financial Results and Press Release for the Quarter ended 30 June 2026
Hester Biosciences Ltd has announced its financial results for the quarter ended 30 June 2026, with a profit of INR 147.11 crore and a total comprehensive income of INR 147.11 crore. The company's revenue from operations was INR 726.60 crore, with a segment-wise revenue of INR 18.16 crore from Poultry Healthcare and INR 108.44 crore from Animal Healthcare. The company's segment results were INR 236.72 crore, with a profit before tax of INR 197.52 crore.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults30 Jul 2026
Associated Alcohols & Breweries Ltd.
Analysts/Institutional Investor Meet/Con. Call Updates
Associated Alcohols & Breweries Ltd. has informed the Exchange about Transcript of Earning/ Investor Conference Call held on 27th July 2026 on Earnings Presentation for the Q1 FY 2026-27. The company reported its highest ever quarterly IMFL proprietary revenue of INR729 million, registering a robust 58% year-on-year growth in value and 40% year-on-year growth in volume.
NSECredit Rating- Revision▲ PositiveRating Change30 Jul 2026
Ambika Cotton Mills Limited
Credit Rating- Revision
Ambika Cotton Mills Limited has informed the Exchange about Credit Rating- Revision. The company's short-term rating has been upgraded to 'Crisil A1+' and its long-term rating has been reaffirmed as 'Crisil A+/Stable'. The upgrade reflects the sustained improvement in the company's liquidity and strengthening financial flexibility over the three fiscals ended March 31, 2026.
NSEOutcome of Board Meeting▲ PositiveResults30 Jul 2026
Hester Biosciences Limited
Outcome of Board Meeting
Hester Biosciences Limited has submitted its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with a profit before exceptional items and tax of ₹197.52 crore and a profit after exceptional item and tax of ₹147.11 crore. The company has also announced the divestment of 43.81% equity shareholding in its subsidiary, Texas Lifescience Private Limited.
BSEBoard Meeting▲ PositiveResults30 Jul 2026
Hester Biosciences Ltd
Outcome of Board Meeting held today
Hester Biosciences Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended 30 June 2026. The company's revenue from operations was INR 26.60 crore, with a net profit of INR 147.11 crore. The results were approved by the Board of Directors in a meeting held on 30 July 2026.
BSECompany Update▲ PositiveRating Change30 Jul 2026
Ambika Cotton Mills Ltd
Filing of Crisil Rating for Bank Facilities
Ambika Cotton Mills Ltd has filed CRISIL rating for bank facilities, with short-term rating upgraded to CRISIL A1+ and long-term rating reaffirmed as CRISIL A+/Stable.
BSECompany Update▲ PositiveResults30 Jul 2026
Associated Alcohols & Breweries Ltd
Transcript of Earning Call for Q1 FY 2026-27
Associated Alcohols & Breweries Ltd reported Q1 FY 2026-27 earnings, with IMFL proprietary segment delivering strong momentum, registering a 58% year-on-year growth in value and 40% year-on-year growth in volume.
BSECompany Update▲ PositiveESG30 Jul 2026
Piccadily Agro Industries Ltd
Press Release dated 30.07.2026
Piccadily Agro Industries Ltd has announced that its whisky brand, Indri, has won top three positions in the Best Indian Whisky and Best Single Malt Indian Whisky categories at the International Whisky Competition 2026.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults30 Jul 2026
Laurus Labs Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Laurus Labs Limited has hosted a Q1 FY27 earnings conference call, discussing strong growth momentum, with revenue of INR2,026 crores, a 29% growth, and EBITDA margins expanding to 31.8%. The company has also signed a development and commercial agreement with Aarvik Therapeutics for 2 ADC molecules and onboarded a big pharma client.
BSECompany Update▲ PositiveResults30 Jul 2026
Laurus Labs Ltd
Please see annexed enclosure.
Laurus Labs Ltd reported Q1 FY27 earnings, with revenue of INR2,026 crores, a 29% growth, driven by commercial supplies in CDMO segment and continued strength in affordable medicine portfolio. Gross margins were healthy at 62.7%, and EBITDA margins expanded to 31.8%. The company signed a development and commercial agreement with Aarvik Therapeutics for 2 ADC molecules for India markets, and onboarded a big pharma client with significant opportunities ahead.
NSEBagging/Receiving of orders/contracts▲ PositiveOrder Win30 Jul 2026
Jindal Drilling And Industries Limited
Bagging/Receiving of orders/contracts
Jindal Drilling And Industries Limited has received a notification of award from Oil & Natural Gas Corporation Limited (ONGC) for the deployment of rig Jindal Pioneer for a period of 3 years at an Effective Day Rate (EDR) of Rs. 45,83,215.16 equivalent to USD 47,893.99. The contract is expected to commence in Q3 FY27.
BSECompany Update▲ PositiveOrder Win30 Jul 2026
Jindal Drilling & Industries Ltd
Award received from Oil & Natural Gas Corporation Ltd (ONGC)
Jindal Drilling & Industries Ltd has received a notification of award from Oil & Natural Gas Corporation Ltd (ONGC) for the deployment of rig Jindal Pioneer for a period of 3 years at an Effective Day Rate (EDR) of Rs. 45,83,215.16 equivalent to USD 47,893.99. The contract is expected to commence in Q3 FY27.
NSEPress Release▲ PositiveResults30 Jul 2026
Rossell Techsys Limited
Press Release
Rossell Techsys Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations surging 78% year-on-year to ₹154.7 crore, and profit before tax (PBT) soaring 139% year-on-year to ₹9.60 crore.
BSECompany Update▲ PositiveResults30 Jul 2026
Rossell Techsys Ltd
Press release pertaining to the financial results for the quarter ended 30 June 2026
Rossell Techsys Ltd reported a record-breaking Q1 FY27 with 78% revenue growth and 139% PBT growth, driven by disciplined execution, expanding customer engagements, and sustained momentum across its core businesses.
BSECompany Update▲ PositiveRegulatory30 Jul 2026
Wanbury Ltd
Press Release - No DMF deficiency letter received from the office of USFDA for multiple ANDAs
Wanbury Ltd received 'No DMF deficiency letter' from USFDA for multiple ANDAs, indicating full compliance with regulatory requirements.
NSEPress Release▲ PositiveRegulatory30 Jul 2026
Wanbury Limited
Press Release
Wanbury Limited has informed the Exchange that it has received a 'No DMF deficiency letter' from the USFDA for multiple ANDAs, indicating full compliance with regulatory requirements.